The results show that TDZs can induce the degradation of cyclin D1 and CDK4, and the expression of p21 and p27, which is consistent with their inhibition of G1 to S-phase progression in colon cancer cells. The gene discussed is CDK4; the disease is malignant colon neoplasm.